These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 29258088)
1. MiR-144 Increases Intestinal Permeability in IBS-D Rats by Targeting OCLN and ZO1. Hou Q; Huang Y; Zhu S; Li P; Chen X; Hou Z; Liu F Cell Physiol Biochem; 2017; 44(6):2256-2268. PubMed ID: 29258088 [TBL] [Abstract][Full Text] [Related]
2. Hou Q; Huang Y; Wang Y; Liao L; Zhu Z; Zhang W; Liu Y; Li P; Chen X; Liu F J Microbiol Biotechnol; 2020 Oct; 30(10):1480-1487. PubMed ID: 32807750 [TBL] [Abstract][Full Text] [Related]
3. miR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea. Martínez C; Rodiño-Janeiro BK; Lobo B; Stanifer ML; Klaus B; Granzow M; González-Castro AM; Salvo-Romero E; Alonso-Cotoner C; Pigrau M; Roeth R; Rappold G; Huber W; González-Silos R; Lorenzo J; de Torres I; Azpiroz F; Boulant S; Vicario M; Niesler B; Santos J Gut; 2017 Sep; 66(9):1537-1538. PubMed ID: 28082316 [TBL] [Abstract][Full Text] [Related]
4. Tong-Xie-Yao-Fang improves intestinal permeability in diarrhoea-predominant irritable bowel syndrome rats by inhibiting the NF-κB and notch signalling pathways. Hou Q; Huang Y; Zhu Z; Liao L; Chen X; Han Q; Liu F BMC Complement Altern Med; 2019 Nov; 19(1):337. PubMed ID: 31775739 [TBL] [Abstract][Full Text] [Related]
5. The Colonic Mucosal MicroRNAs, MicroRNA-219a-5p, and MicroRNA-338-3p Are Downregulated in Irritable Bowel Syndrome and Are Associated With Barrier Function and MAPK Signaling. Mahurkar-Joshi S; Rankin CR; Videlock EJ; Soroosh A; Verma A; Khandadash A; Iliopoulos D; Pothoulakis C; Mayer EA; Chang L Gastroenterology; 2021 Jun; 160(7):2409-2422.e19. PubMed ID: 33617890 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of miR-429 impairs intestinal barrier function in diabetic mice by down-regulating occludin expression. Yu T; Lu XJ; Li JY; Shan TD; Huang CZ; Ouyang H; Yang HS; Xu JH; Zhong W; Xia ZS; Chen QK Cell Tissue Res; 2016 Nov; 366(2):341-352. PubMed ID: 27299781 [TBL] [Abstract][Full Text] [Related]
7. Decreased miR-199 augments visceral pain in patients with IBS through translational upregulation of TRPV1. Zhou Q; Yang L; Larson S; Basra S; Merwat S; Tan A; Croce C; Verne GN Gut; 2016 May; 65(5):797-805. PubMed ID: 25681400 [TBL] [Abstract][Full Text] [Related]
8. Regulation of Colonic Mucosal MicroRNA Expression via Multiple Targets in Visceral Hypersensitivity Rats by Tongxieyaofang. Chao G; Wang Y; Ye F; Zhang S Yonsei Med J; 2018 Oct; 59(8):945-950. PubMed ID: 30187701 [TBL] [Abstract][Full Text] [Related]
9. MiR-34c and PlncRNA1 mediated the function of intestinal epithelial barrier by regulating tight junction proteins in inflammatory bowel disease. Chen T; Xue H; Lin R; Huang Z Biochem Biophys Res Commun; 2017 Apr; 486(1):6-13. PubMed ID: 28153728 [TBL] [Abstract][Full Text] [Related]
10. Chang-Kang-Fang alleviates diarrhea predominant irritable bowel syndrome (IBS-D) through inhibiting TLR4/NF-κB/NLRP3 pathway. Zhang S; Tian D; Xia Z; Yang F; Chen Y; Yao Z; He Y; Miao X; Zhou G; Yao X; Tang J J Ethnopharmacol; 2024 Aug; 330():118236. PubMed ID: 38670405 [TBL] [Abstract][Full Text] [Related]
11. Silencing interleukin 1α underlies a novel inhibitory role of miR-181c-5p in alleviating low-grade inflammation of rats with irritable bowel syndrome. Ji LJ; Li F; Zhao P; Weng LP; Wei J; Yan J; Liu LN J Cell Biochem; 2019 Sep; 120(9):15268-15279. PubMed ID: 31172560 [TBL] [Abstract][Full Text] [Related]
12. miR-130a and miR-212 Disrupt the Intestinal Epithelial Barrier through Modulation of PPARγ and Occludin Expression in Chronic Simian Immunodeficiency Virus-Infected Rhesus Macaques. Kumar V; Mansfield J; Fan R; MacLean A; Li J; Mohan M J Immunol; 2018 Apr; 200(8):2677-2689. PubMed ID: 29514950 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-200a Targets Cannabinoid Receptor 1 and Serotonin Transporter to Increase Visceral Hyperalgesia in Diarrhea-predominant Irritable Bowel Syndrome Rats. Hou Q; Huang Y; Zhang C; Zhu S; Li P; Chen X; Hou Z; Liu F J Neurogastroenterol Motil; 2018 Oct; 24(4):656-668. PubMed ID: 30347941 [TBL] [Abstract][Full Text] [Related]
14. Momordica charantia polysaccharides alleviate diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and barrier via NF-κB pathway. Ji S; Zhang Q Allergol Immunopathol (Madr); 2022; 50(3):62-70. PubMed ID: 35527657 [TBL] [Abstract][Full Text] [Related]
15. The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype. Bertiaux-Vandaële N; Youmba SB; Belmonte L; Lecleire S; Antonietti M; Gourcerol G; Leroi AM; Déchelotte P; Ménard JF; Ducrotté P; Coëffier M Am J Gastroenterol; 2011 Dec; 106(12):2165-73. PubMed ID: 22008894 [TBL] [Abstract][Full Text] [Related]
16. MiRNA-29a modulates visceral hyperalgesia in irritable bowel syndrome by targeting HTR7. Zhu H; Xiao X; Chai Y; Li D; Yan X; Tang H Biochem Biophys Res Commun; 2019 Apr; 511(3):671-678. PubMed ID: 30827505 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-24 inhibits serotonin reuptake transporter expression and aggravates irritable bowel syndrome. Liao XJ; Mao WM; Wang Q; Yang GG; Wu WJ; Shao SX Biochem Biophys Res Commun; 2016 Jan; 469(2):288-93. PubMed ID: 26631964 [TBL] [Abstract][Full Text] [Related]
18. Atractylodes oil alleviates diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and intestinal barrier via SCF/c-kit and MLCK/MLC2 pathways. Xie Y; Zhan X; Tu J; Xu K; Sun X; Liu C; Ke C; Cao G; Zhou Z; Liu Y J Ethnopharmacol; 2021 May; 272():113925. PubMed ID: 33592255 [TBL] [Abstract][Full Text] [Related]
19. Compromised barrier integrity of human feto-placental vessels from gestational diabetic pregnancies is related to downregulation of occludin expression. Villota SD; Toledo-Rodriguez M; Leach L Diabetologia; 2021 Jan; 64(1):195-210. PubMed ID: 33001231 [TBL] [Abstract][Full Text] [Related]
20. Berberine Enhances Intestinal Mucosal Barrier Function by Promoting Vitamin D Receptor Activity. Huang YQ; Liu JL; Chen GX; Shen DT; Zhu W; Chen XL; Liu FB; Hou QK Chin J Integr Med; 2024 Feb; 30(2):143-151. PubMed ID: 37046128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]